Medicare coverage of targeted disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) -- both under Medicare Advantage and in separate Part D plans -- is likely to leave many ...
Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.
Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...
RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...
Regular cinnamon consumption may lower RA disease activity and symptoms, studies show. Learn how experts recommend getting your daily dose.
ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b ...
UK: Researchers have found in a new study that patients with rheumatoid arthritis have an elevated risk of interstitial lung ...
First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon by healthcare professionals and organisations ...
Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, has been associated with lack of response to first-line therapy in the Care ...
First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon ...
The European Alliance of Associations for Rheumatology – updated its recommendations on the treatment of rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs (DMARD). The 2025 update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results